Average Co-Inventor Count = 2.42
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Texas System (15 from 5,448 patents)
2. Miragen Therapeutics, Inc. (9 from 20 patents)
23 patents:
1. 10392618 - Micro-RNA family that modulates extracellular matrix genes and uses thereof
2. 10337005 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif
3. 9994847 - miR-29 mimics and uses thereof
4. 9803202 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif
5. 9752143 - Locked nucleic acid inhibitor of miR-145 and uses thereof
6. 9719088 - Micro-RNA family that modulates fibrosis and uses thereof
7. 9719086 - Micro-RNA family that modulates fibrosis and uses thereof
8. 9719087 - Micro-RNA family that modulates fibrosis and uses thereof
9. 9428749 - Control of whole body energy homeostasis by microRNA regulation
10. 9388408 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif
11. 9376681 - miR-29 mimics and uses thereof
12. 9163235 - Inhibitors of the miR-15 family of micro-RNAs
13. 9078919 - Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair
14. 9072765 - Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure
15. 8962588 - Micro-RNAS that control myosin expression and myofiber identity